Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 8, 2015, Pages 706-713

  Li, Jingzhen ^a   Wang, Lijuan ^a   Hu, Jinzhu ^a   Xu, Gaosi ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Bleeding; Hemodialysis; Stroke; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; HEMODIALYSIS; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ATRIAL FIBRILLATION; CHEMICALLY INDUCED; COMPLICATION; HEMORRHAGE; RENAL REPLACEMENT THERAPY; RISK FACTOR; STROKE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HEMORRHAGE; HUMANS; RENAL DIALYSIS; RISK FACTORS; STROKE; WARFARIN;

EID: 84937519054     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.03.013     Document Type: Article

References (38)

1. Abe S., Yoshizawa M., Nakanishi N., Yazawa T., Yokota K., Honda M., et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996-06-01, 131(6):1137-1144.
2. Fabbian F., Catalano C., Lambertini D., Tarroni G., Bordin V., Squerzanti R., et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 2000-09-01, 54(3):234-239.
3. Vazquez E., Sanchez-Perales C., Borrego F., Garcia-Cortes M.J., Lozano C., Guzman M., et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000-12-01, 140(6):886-890.
4. Genovesi S., Pogliani D., Faini A., Valsecchi M.G., Riva A., Stefani F., et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005-11-01, 46(5):897-902.
5. Bologa R.M., Levine D.M., Parker T.S., Cheigh J.S., Serur D., Stenzel K.H., et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998-07-01, 32(1):107-114.
6. Landray M.J., Wheeler D.C., Lip G.Y., Newman D.J., Blann A.D., McGlynn F.J., et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004-02-01, 43(2):244-253.
7. Shlipak M.G., Fried L.F., Crump C., Bleyer A.J., Manolio T.A., Tracy R.P., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003-01-07, 107(1):87-92.
8. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998-09-08, 98(10):946-952.
9. Zimmerman D., Sood M.M., Rigatto C., Holden R.M., Hiremath S., Clase C.M. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 2012-10-01, 27(10):3816-3822.
10. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007-06-19, 146(12):857-867.
11. Reinecke H., Brand E., Mesters R., Schabitz W.R., Fisher M., Pavenstadt H., et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2009-04-01, 20(4):705-711.
12. Winkelmayer W.C., Liu J., Setoguchi S., Choudhry N.K. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 2011-11-01, 6(11):2662-2668.
13. Wizemann V., Tong L., Satayathum S., Disney A., Akiba T., Fissell R.B., et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010-06-01, 77(12):1098-1106.
14. Chan K.E., Lazarus J.M., Thadhani R., Hakim R.M. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009-10-01, 20(10):2223-2233.
15. Olesen J.B., Lip G.Y., Kamper A.L., Hommel K., Kober L., Lane D.A., et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012-08-16, 367(7):625-635.
16. Eiser A.R. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines. Am J Med 2014-04-01, 127(4):253-254.
17. Genovesi S., Rossi E., Pogliani D., Gallieni M., Stella A., Badiali F., et al. The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation. J Nephrol 2014-04-01, 27(2):187-192.
18. Connolly S.J., Ezekowitz M.D., Yusuf S., Eikelboom J., Oldgren J., Parekh A., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009-09-17, 361(12):1139-1151.
19. Higgins J.P., Altman D.G., Gotzsche P.C., Juni P., Moher D., Oxman A.D., et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011-01-20, 343:d5928.
20. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010-09-01, 25(9):603-605.
21. Wakasugi M., Kazama J.J., Tokumoto A., Suzuki K., Kageyama S., Ohya K., et al. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study. Clin Exp Nephrol 2014-08-01, 18(4):662-669.
22. Shah M., Avgil T.M., Jackevicius C.A., Essebag V., Eisenberg M.J., Rahme E., et al. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 2014-03-18, 129(11):1196-1203.
23. Zellweger M., Bouchard J., Raymond-Carrier S., Laforest-Renald A., Querin S., Madore F. Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J 2005-07-01, 51(4):360-365.
24. Obialo C.I., Conner A.C., Lebon L.F. Maintaining patency of tunneled hemodialysis catheters-efficacy of aspirin compared to warfarin. Scand J Urol Nephrol 2003-01-20, 37(2):172-176.
25. LeSar C.J., Merrick H.W., Smith M.R. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg 1999-07-01, 189(1). 73-9, 79-81.
26. Skanes A.C., Healey J.S., Cairns J.A., Dorian P., Gillis A.M., McMurtry M.S., et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 2012-03-01, 28(2):125-136.
27. Presnell S.R., Stafford D.W. The vitamin K-dependent carboxylase. Thromb Haemost 2002-06-01, 87(6):937-946.
28. Holden R.M., Sanfilippo A.S., Hopman W.M., Zimmerman D., Garland J.S., Morton A.R. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 2007-07-01, 20(4):417-422.
29. Coates T., Kirkland G.S., Dymock R.B., Murphy B.F., Brealey J.K., Mathew T.H., et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 1998-09-01, 32(3):384-391.
30. Rockx M.A., Sood M.M. A necrotic skin lesion in a dialysis patient after the initiation of warfarin therapy: a difficult diagnosis. J Thromb Thrombolysis 2010-01-01, 29(1):130-133.
31. Reynolds M.W., Fahrbach K., Hauch O., Wygant G., Estok R., Cella C., et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest 2004-12-01, 126(6):1938-1945.
32. Ageno W., Gallus A.S., Wittkowsky A., Crowther M., Hylek E.M., Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012-02-01, 141(2 Suppl.):e44S-e88S.
33. Kirkwood T.B. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983-06-28, 49(3):238-244.
34. Coli L., Donati G., Cianciolo G., Raimondi C., Comai G., Panicali L., et al. Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access 2006-07-01, 7(3):118-122.
35. Lai H.M., Aronow W.S., Kalen P., Adapa S., Patel K., Goel A., et al. Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renov Dis 2009-01-20, 2:33-37.
36. Praehauser C., Grandjean R., Steiger J., Mayr M. Cohort study on the quality of oral anticoagulation therapy in chronic haemodialysis patients treated with phenprocoumon. Swiss Med Wkly 2013-01-20, 143:w13730.
37. Yang F., Chou D., Schweitzer P., Hanon S. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?. Europace 2010-12-01, 12(12):1666-1672.
38. Thet Z., Vilayur E. Atrial fibrillation and warfarin use in haemodialysis patients: an individualized holistic approach is important in stroke prevention. Nephrology (Carlton) 2013-05-01, 18(5):331-339.